Trials / Completed
CompletedNCT01766050
Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers
An Open-label, Single-sequence Study of the Effect of Belatacept on the Pharmacokinetics of Caffeine, Losartan, Omeprazole, Dextromethorphan, and Midazolam Administered as "Inje Cocktail" in Healthy Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effects of belatacept on the pharmacokinetics of caffeine, losartan, omeprazole, dextromethorphan and midazolam
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caffeine | |
| DRUG | Losartan | |
| DRUG | Omeprazole | |
| DRUG | Dextromethorphan | |
| DRUG | Midazolam | |
| BIOLOGICAL | Belatacept |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-01-11
- Last updated
- 2014-06-27
- Results posted
- 2014-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01766050. Inclusion in this directory is not an endorsement.